Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / SPON ADS
-
Number of holders
-
67
-
Total shares
-
111M
-
Shares change
-
+1.37M
-
Total reported value, excl. options
-
$257M
-
Value change
-
+$2.93M
-
Put/Call ratio
-
0
-
Number of buys
-
19
-
Number of sells
-
-32
-
Price
-
$2.33
Significant Holders of Autolus Therapeutics plc - SPON ADS (AUTL) as of Q3 2023
67 filings reported holding AUTL - Autolus Therapeutics plc - SPON ADS as of Q3 2023.
Autolus Therapeutics plc - SPON ADS (AUTL) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111M shares
.
Largest 10 shareholders include Syncona Portfolio Ltd (21.3M shares), Blackstone Inc. (20.5M shares), Deep Track Capital, LP (15M shares), Paradigm Biocapital Advisors LP (14.4M shares), TFG Asset Management GP Ltd (12M shares), ARMISTICE CAPITAL, LLC (6.9M shares), Frazier Life Sciences Management, L.P. (3.75M shares), Affinity Asset Advisors, LLC (1.99M shares), Perpetual Ltd (1.97M shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (1.67M shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.